Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | -1.10M | -1.72M | -2.19M | -2.61M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 809.40K | -47.20K | 409.10K | 166.70K | 604.50K |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -1.12M | -1.15M | -1.31M | -2.02M | -2.00M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 163.10K | 638.50K | 567.60K | 881.60K | 908.00K |
| Total Debt Repaid | -495.20K | -252.30K | -286.90K | -209.60K | -216.60K |
| Issuance of Common Stock | 1.86M | 1.25M | 1.68M | 2.14M | 1.81M |
| Repurchase of Common Stock | -14.30K | -14.30K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.08M | 1.15M | 1.40M | 2.02M | 1.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.00K | -400.00 | 89.70K | 3.20K | -185.20K |